ArticleJACC. Case reports2026
Danon Disease Diagnosed by Multimodal Imaging.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDanon disease is a rare X-linked dominant disorder caused by loss-of-function mutations in lysosome-associated membrane protein-2 (LAMP2). CASE SUMMARY: We report an 18-year-old male patient in which multimodal imaging revealed left ventricular hypertrophy, reduced myocardial perfusion, electrocardiographic evidence of pre-excitation, abnormal serologic parameters, and histopathologic abnormalities. Genetic testing identified a variant in LAMP2, confirming the diagnosis of Danon disease. Testing of his mother and 3 children also revealed the LAMP2 variant. DISCUSSION: Patients with Danon disease primarily present with cardiac manifestations, including hypertrophic cardiomyopathy, arrhythmia, and heart failure. TAKE-HOME MESSAGES: Young men exhibiting myocardial hypertrophy, elevated plasma creatine kinase, pre-excitation on electrocardiography, and/or characteristic late gadolinium enhancement on cardiac magnetic resonance should be evaluated for Danon disease. Multimodal imaging (echocardiography, cardiac magnetic resonance) combined with genetic testing is key to accurate diagnosis. Family screening and genetic counseling are crucial given the X-linked dominant-inheritance pattern.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.